Metabolic Health
EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Clinical Trial
Jun 18, 2026 0
Results for "Bempedoic Acid" in Diabetes
20 articles
Metabolic Health
Metformin Shows Promise for Protecting Memory in Early Cognitive Decline
Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.
Clinical Trial
Mar 29, 2026 1
Metabolic Health
New Anemia Drug GSK1278863 Tested as Replacement for EPO in Kidney Disease Patients
A Phase IIa trial explores whether the HIF-PHI drug daprodustat can safely replace EPO injections in hemodialysis patients with anemia.
Clinical Trial
May 26, 2026 0
Metabolic Health
Common Medications May Block Vitamin B1 Absorption in Small Clinical Trial
UCSF study reveals how metformin and trimethoprim interfere with thiamine uptake, potentially affecting energy metabolism.
Clinical Trial
Mar 29, 2026 2
Metabolic Health
NAD Precursor Combo Tested to Boost Muscle Mitochondria in Elderly Adults
Maastricht University investigated whether NA, NAM, and tryptophan together could restore mitochondrial function in physically compromised older adults.
Clinical Trial
May 8, 2026 0
Metabolic Health
Metformin Shows Promise for Healthy Aging in Non-Diabetic Adults
Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
New Drug GFT505 Shows Promise for Fatty Liver Disease in Phase IIb Trial
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
Clinical Trial
Mar 28, 2026 2
Metabolic Health
Metformin Shows Promise for Improving Blood Vessel Health in Metabolic Syndrome
Four-year study examined whether metformin could protect blood vessels in people with metabolic syndrome beyond its diabetes benefits.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
PCSK9 Inhibitor Alirocumab Outperforms Usual Care in Diabetic Mixed Dyslipidemia
Phase 4 trial tests whether alirocumab can better control non-HDL cholesterol in high-risk type 2 diabetics failing statin therapy.
Clinical Trial
Jun 16, 2026 0
Metabolic Health
CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
Clinical Trial
Jun 16, 2026 0
Metabolic Health
How Common Drugs Shift Oxygen Delivery in the Blood
Researchers mapped how anesthetics, nitric oxide, and other drugs alter hemoglobin's grip on oxygen — with real implications for critical care.
Clinical Trial
May 9, 2026 0
Metabolic Health
Intensive Diabetes Control Study Shows Mixed Results for Heart Disease Prevention
Major trial of 10,251 diabetics reveals surprising outcomes from aggressive blood sugar, blood pressure, and cholesterol management.
Clinical Trial
Mar 28, 2026 8
Metabolic Health
Triple Therapy Targets Diabetes and Muscle Loss in Elderly Adults
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Diabetes Drug Exenatide Shows Promise for Weight Loss in Prediabetic Adults
Stanford study tests whether GLP-1 drug exenatide can restore insulin function and promote weight loss in people with prediabetes.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Metformin Shows Promise for Preventing Frailty in Older Adults
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Metformin May Help or Harm Aging Based on Your Insulin Sensitivity
New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Diabetes Drug Pioglitazone Shows Promise for Reversing Fatty Liver Disease
176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.
Clinical Trial
Mar 29, 2026 2
Metabolic Health
Cysteine and Glycine Supplements May Restore Glutathione and Fat Burning in Aging Muscle
A completed trial investigates whether replenishing glutathione precursors can reverse metabolic dysfunction in elderly adults.
Clinical Trial
Jun 20, 2026 0
Metabolic Health
Once-Weekly Insulin Efsitora Alfa Tested Against Daily Degludec in Type 1 Diabetes
Eli Lilly's phase 3 trial pits a novel weekly basal insulin against the gold-standard daily insulin degludec in type 1 diabetes patients.
Clinical Trial
Jun 16, 2026 0
Metabolic Health
Six Weeks of Endurance Training Activates Brown Fat for Better Metabolism
New study reveals how endurance exercise transforms fat-burning brown adipose tissue in just six weeks of training.
Clinical Trial
Mar 29, 2026 0
Page 1 of 2Next